Biotech Series A Investors & VC Firms
11 firms in this list, with a median first check of $1M. 4 of them lead rounds. Generated from verified public data and updated continuously.
Third Rock Ventures
BostonSeed–Series C
Lerer Hippeau
New YorkSeed–Series B
LSP (Life Sciences Partners)
StockholmSeries A–Late Stage$11M – $66M
Medicxi
LondonPre-Seed–Series C
Osage University Partners
Pre-Seed–Late Stage$1M – $20M
Innovestor Ventures
HelsinkiPre-Seed–Growth
Menlo Ventures
San FranciscoPre-Seed–Growth
Starfish Ventures
SydneySeed–Series B
Octopus Ventures
LondonPre-Seed–Late Stage$125K
DCVC (Data Collective)
San FranciscoSeed–Late Stage
Andreessen Horowitz
Menlo ParkSeed–Growth
Related lists
Series A Investors & VC Firms (114)AI & Machine Learning Series A Investors & VC Firms (30)Biotech Investors & VC Firms (21)Fintech Series A Investors & VC Firms (19)Healthtech Series A Investors & VC Firms (18)SaaS Series A Investors & VC Firms (17)Enterprise Software Series A Investors & VC Firms (16)Biotech Seed Investors & VC Firms (16)Series A Investors & VC Firms in San Francisco (13)Climate Tech Series A Investors & VC Firms (12)
Data sourced from public filings and firms' own websites — see our methodology.